Cost-effectiveness of adding bedaquiline to drug regimens for the treatment of multidrug-resistant tuberculosis in the UK
about
Management of multidrug-resistant TB: novel treatments and their expansion to low resource settingsBedaquiline as part of combination therapy in adults with pulmonary multi-drug resistant tuberculosis.Health outcomes of bedaquiline in the treatment of multidrug-resistant tuberculosis in selected high burden countries.Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in GermanyCost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy.WHO strategies for the programmatic management of drug-resistant tuberculosis.News on therapeutic management of MDR-tuberculosis: a literature review.Comparison of Effectiveness Between Delamanid and Bedaquiline Among Patients with Multidrug-Resistant Tuberculosis: A Markov Model Simulation Study.Incremental Cost Effectiveness of Bedaquiline for the Treatment of Rifampicin-Resistant Tuberculosis in South Africa: Model-Based Analysis.Structure-activity relationships for analogs of the tuberculosis drug bedaquiline with the naphthalene unit replaced by bicyclic heterocycles.
P2860
Q26765394-4E43D206-1269-4FBE-B7D6-7068FD3CD1E3Q30249515-2DDCB412-BD69-4DEC-9F9D-10584A0BB90DQ36260334-52AE6B5C-3FE5-4FD0-A6ED-799CFCBE178BQ36300175-5E67C2C9-6814-4FD6-A551-9FFEBD51E252Q37669577-6E88AB2E-A863-4BFB-B414-743490083E6CQ38856343-7AD3675F-EF27-4E76-9D19-890B76149EDFQ39398924-FCF44213-D160-4CAC-89E4-7CCAFBDFD867Q39553356-34E86D42-4F1F-4EA8-93AB-2023C2D350ECQ46959941-14460575-C29E-43CD-A143-458A7A497041Q51747372-7C1D4CEB-54FA-49C0-AC15-F979526878A7
P2860
Cost-effectiveness of adding bedaquiline to drug regimens for the treatment of multidrug-resistant tuberculosis in the UK
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Cost-effectiveness of adding b ...... sistant tuberculosis in the UK
@ast
Cost-effectiveness of adding b ...... sistant tuberculosis in the UK
@en
Cost-effectiveness of adding b ...... sistant tuberculosis in the UK
@nl
type
label
Cost-effectiveness of adding b ...... sistant tuberculosis in the UK
@ast
Cost-effectiveness of adding b ...... sistant tuberculosis in the UK
@en
Cost-effectiveness of adding b ...... sistant tuberculosis in the UK
@nl
prefLabel
Cost-effectiveness of adding b ...... sistant tuberculosis in the UK
@ast
Cost-effectiveness of adding b ...... sistant tuberculosis in the UK
@en
Cost-effectiveness of adding b ...... sistant tuberculosis in the UK
@nl
P2093
P2860
P1433
P1476
Cost-effectiveness of adding b ...... sistant tuberculosis in the UK
@en
P2093
Andrew Murungi
Anna Walker
Chrispin Kambili
Gerhart Knerer
Robert Hettle
Xiaoyan Lu
P2860
P304
P356
10.1371/JOURNAL.PONE.0120763
P407
P577
2015-01-01T00:00:00Z